BlackRock Japan’s Kyntra Bio KYNB Stock Holding History

BlackRock Japan’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$35K	Buy	66 +8	+14%	+$4K	﹤0.01%	1035
2016 Q3	$30K	Sell	58 -8	-12%	-$3.77K	﹤0.01%	1055
2016 Q2	$27K	Buy	66 +44	+200%	+$20.1K	﹤0.01%	1105
2016 Q1	$12K	Sell	22 -1	-4%	-$498	﹤0.01%	1260
2015 Q4	$17K	Sell	23 -30	-57%	-$19.9K	﹤0.01%	1187
2015 Q3	$29K	Sell	53 -441	-89%	-$267K	﹤0.01%	1053
2015 Q2	$290K	Buy	+494	New	+$287K	﹤0.01%	828
2015 Q1	–	Sell	-8	Closed	-$6K	–	1319
2014 Q4	$6K	Buy	+8	New	+$5.15K	﹤0.01%	1303

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

BlackRock Japan's KYNB Position: Q4 2016 in Review

BlackRock Japan increased its Kyntra Bio (KYNB) stake by 14% in Q4 2016, buying an estimated $4K and bringing the position to 66 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

BlackRock Japan first reported a position in KYNB in Q4 2014 and has held it in 8 quarters since. The position peaked at $290K in Q2 2015. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

BlackRock Japan held 66 shares of Kyntra Bio worth $35K as of Q4 2016.
BlackRock Japan bought 8 Kyntra Bio shares in Q4 2016, an estimated $4K.
Kyntra Bio made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1035 holding.
BlackRock Japan first reported a position in Kyntra Bio in Q4 2014 and has held it in 8 quarters since.
BlackRock Japan's Kyntra Bio position peaked at $290K in Q2 2015.
140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.